Boehringer Ingelheim GmbH et al. v. AbbVie Biotechnology Ltd. > Summary
Court Case Number IPR2016-00408
Filing Date Dec 29, 2015
Institution Decision Date Jul 7, 2016
Decision Date Jul 6, 2017
Court Patent Trial and Appeal Board
Status Final Written Decision
Appeal2017-2304
Administrative JudgesSusan L. C. Mitchell, Sheridan K. Snedden, Michelle N. Ankenbrand
Judge Writing the Final DecisionSusan L. C. Mitchell
Claims Challenged in the Petition: 1, 2, 3, 4, 5
Claims Instituted: 1, 2, 3, 4, 5
Claims Invalidated: 1, 2, 3, 4, 5
Petitioner
Patent Owner
Petitioner Attorneys
10Boehringer Ingelheim International GmbH
Attorney Name: James W. Evans
Paul Hastings
Boehringer Ingelheim International GmbH
Attorney Name: Bruce M. Wexler
Paul Hastings
Boehringer Ingelheim International GmbH
Attorney Name: Eric W. Dittmann
Paul Hastings
Boehringer Ingelheim International GmbH
Attorney Name: Naveen Modi
Paul Hastings
Boehringer Ingelheim International GmbH
Attorney Name: Colin G. Cabral
Proskauer Rose
Boehringer Ingelheim International GmbH
Attorney Name: Siegmund Y. Gutman
Proskauer Rose
Boehringer Ingelheim International GmbH
Attorney Name: Eric W. Dittmann
Paul Hastings
Boehringer Ingelheim International GmbH
Attorney Name: Naveen Modi
Paul Hastings
Attorney Name: Isaac S. Ashkenazi
Paul Hastings
Patent Owner Attorneys
7AbbVie Biotechnology
Attorney Name: Steven P. O’Connor
Finnegan, Henderson, Farabow, Garrett & Dunner
Attorney Name: Charles E. Lipsey
Finnegan, Henderson, Farabow, Garrett & Dunner
Attorney Name: John M. Williamson
Finnegan, Henderson, Farabow, Garrett & Dunner
Attorney Name: Scott E. Kamholz
Foley Hoag
Attorney Name: William G. McElwain
Wilmer Cutler Pickering Hale and Dorr
Attorney Name: Amy K. Wigmore
Wilmer Cutler Pickering Hale and Dorr
Related Patents
Doc No | Title | Issue date |
---|---|---|
08889135 | Methods of administering anti-TNFα antibodies | Nov 18, 2014 |